Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

EVCM vs SGHT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EVCM Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

EVCM Overall Winner 6-Pillar Tally: EVCM 4 – 2 SGHT Matrix Metrics: EVCM 7 – 3 SGHT

As of Nov 16, 2026, EverCommerce Inc. (EVCM) is the stronger overall head-to-head candidate over Sight Sciences, Inc. (SGHT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EVCM carries a Unified Composite Score of 42.7/100 (HOLD) at $6.21 (9.2x Forward P/E, 9.5% operating margin), whereas SGHT carries 35.1/100 (SELL) at $10.59 (N/M Forward P/E, -20.2% operating margin).

  • Growth vs. Quality Trade-Off: EVCM earns the overall head-to-head edge with a stronger Unified Composite Score (42.7/100 HOLD vs. SGHT 35.1/100 SELL) and 0.68β · 62% Vol risk profile, whereas SGHT leads top-line expansion (+25.2% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: EVCM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.5); meanwhile SGHT trades in a Markup technical trend (BREAKOUT options phase, RSI 64.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EVCM vs SGHT
EVCM NASDAQ Head-to-Head Winner
EverCommerce Inc. Common Stock
Services-Prepackaged Software
$6.21
-1.82% 1D
Market Cap $1.2B
TTM Revenue $602M
Forward P/E 9.2x
Beta / 30D Vol 0.68β · 62% Vol
Unified Composite Score
42.7 / 100 HOLD
Tech 35.0 Fund 42.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.4%), weak momentum, RSI 22
RSI-14: 22.5 · SMA20: $8.37 · SMA50: $8.40
SGHT NASDAQ
Sight Sciences, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$10.59
-2.22% 1D
Market Cap $610.8M
TTM Revenue $88M
Forward P/E N/M
Beta / 30D Vol 1.06β · 46% Vol
Unified Composite Score
35.1 / 100 SELL
Tech 50.0 Fund 32.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (7.0% over 20 days), RSI 65
RSI-14: 64.5 · SMA20: $9.74 · SMA50: $9.01

6-Pillar Scorecard Institutional Category Breakdown (EVCM 4 – 2 SGHT)

Columns: Metric · EVCM · SGHT
1. Valuation Multiples EVCM
Forward P/E 9.2x N/M
Trailing P/E 43.6x N/M
PEG Ratio 0.30x N/M
EV / Revenue 2.0x 6.5x
2. Growth & Scale SGHT
Revenue Growth (YoY) +2.7% +25.2%
Earnings Growth (YoY) -49.1% +0.0%
TTM Revenue (USD) $602M $88M
Market Cap $1.2B $610.8M
3. Profitability & Quality EVCM
Gross Margin 78.3% 87.7%
Operating Margin 9.5% -20.2%
Net Profit Margin 4.8% -32.1%
Return on Equity (ROE) 4.0% -50.1%
4. Balance Sheet & Cash Flow EVCM
Cash Generation (TTM) $105M EBITDA -$17M
Cash Flow Margin 17.5% EBITDA Mgn -19.1%
Net Cash / Leverage $4.01 Book/Sh · 4.0% ROE $35M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SGHT
Options Structure Phase UNCLASSIFIED BREAKOUT
Current IV / %ile N/A (N/A) 78.7% (8th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown ACCUMULATION · Markup
6. R&D & Supply-Chain Moat EVCM
OpEx & R&D Intensity 68.8% of Rev ($414M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Application Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EVCM (7) vs SGHT (3)
Institutional Metric EVCM SGHT Criterion Row Edge
Market Capitalization
Scale
$1.2B $610.8M Larger Scale EVCM
Trailing P/E Ratio
Valuation
43.6x N/M Lower Multiple EVCM
Forward P/E Ratio
Valuation
9.2x N/M Lower Multiple EVCM
Revenue Growth (YoY)
Growth
+2.7% +25.2% Higher Growth SGHT
Operating Margin (TTM)
Profitability
9.5% -20.2% Higher Margin EVCM
Net Profit Margin
Profitability
4.8% -32.1% Higher Margin EVCM
Return on Equity (ROE)
Capital Efficiency
4.0% -50.1% Higher ROE EVCM
52-Week Range Position
Momentum
2% ($6–$14) 88% ($3–$12) Stronger Trend SGHT
Beta / 30D Volatility
Risk Regime
0.68β · 62% Vol 1.06β · 46% Vol Lower Realized Risk SGHT
Unified Institutional Score
Composite Signal
42.7 / 100 (HOLD) 35.1 / 100 (SELL) Higher Composite EVCM
Trailing 12M Revenue (USD)
Operating Scale
$602M $88M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
78.3% 87.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.30x PEG · 2.0x EV/Rev N/M PEG · 6.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$105M EBITDA ($4.01 Book/Sh · 4.0% ROE) -$17M ($35M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SGHT +61.85 pp
EVCM: -33.95% · SGHT: +27.9%
3M Horizon SGHT +66.56 pp
EVCM: -37.73% · SGHT: +28.83%
6M Horizon SGHT +156.37 pp
EVCM: -38.47% · SGHT: +117.9%
1Y Horizon SGHT +78.94 pp
EVCM: -28.73% · SGHT: +50.21%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVCM vs SGHT. Trailing 12-month operating profitability (EVCM 9.5% vs SGHT -20.2%) and valuation multiples (EVCM 9.2x vs SGHT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

EVCM ADR TTM Benchmark FX-Normalized USD
TTM Revenue$602M
Gross Margin78.3%
Op. Margin9.5%
ROE / Fwd P/E4.0% · 9.2x
SGHT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$88M
Gross Margin87.7%
Op. Margin-20.2%
ROE / Fwd P/E-50.1% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EVCM UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact EVCM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SGHT BREAKOUT
33d in phase · OBV ACCUMULATION
Current IV 78.7%
IV Percentile 8th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact SGHT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EVCM Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $1.2B market capitalization and 9.5% operating margin.
OpEx & R&D Reinvestment 68.8% of Rev ($414M)
90D Engineering Disclosures 0 Published
SGHT Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $610.8M market capitalization and -20.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ EVCM vs SGHT Key Questions & Quantitative Answers

As of Nov 16, 2026, EverCommerce Inc. (EVCM) is the stronger overall head-to-head candidate over Sight Sciences, Inc. (SGHT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EVCM carries a Unified Composite Score of 42.7/100 (HOLD) at $6.21 (9.2x Forward P/E, 9.5% operating margin), whereas SGHT carries 35.1/100 (SELL) at $10.59 (N/M Forward P/E, -20.2% operating margin). Growth vs. Quality Trade-Off: EVCM earns the overall head-to-head edge with a stronger Unified Composite Score (42.7/100 HOLD vs. SGHT 35.1/100 SELL) and 0.68β · 62% Vol risk profile, whereas SGHT leads top-line expansion (+25.2% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: EVCM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.5); meanwhile SGHT trades in a Markup technical trend (BREAKOUT options phase, RSI 64.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SGHT leads the Growth & Scale pillar: EVCM posts +2.7% YoY revenue growth and -49.1% YoY earnings growth on $602M TTM revenue (78.3% gross margin, 9.5% operating margin), compared with SGHT at +25.2% YoY revenue growth and +0.0% YoY earnings growth on $88M TTM revenue (87.7% gross margin, -20.2% operating margin). On trailing 12-month operating scale, EVCM generates $602M in USD-normalized revenue versus $88M for SGHT. In operating R&D and SG&A reinvestment, EVCM deploys 68.8% of Rev ($414M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SGHT.

EVCM screens cheaper on headline valuation multiples. EVCM trades at 9.2x Forward P/E, 43.6x Trailing P/E, 0.30x PEG, and 2.0x EV/Revenue (17.5% EBITDA margin), whereas SGHT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 6.5x EV/Revenue (-19.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EVCM (4.0% ROE) versus SGHT (-50.1% ROE) capital efficiency.

In options market volatility and institutional positioning, EVCM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.68β · 62% Vol realized risk). By comparison, SGHT carries 78.7% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKOUT options structure phase (1.06β · 46% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.